A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT05366036 · COMPLETED
Trial details
- NCT number
- NCT05366036
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-14
- Primary completion
- 2022-01-14
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.